Jinlan 98+ EP/BP/USP Zanubrutinib
1691249-45-2
medical grade
98%
Shanghai/Ningbo/Qingdao
Jinlan
25kg/Cardboard Drum
2026-04-15
Peptides,API,Intermediate
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
Other Name:Pyrazolo[1,5-a]pyrimidine-3-carboxamide,4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-,(7S)-;(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide;Zanubrutinib;Brukinsa
CAS No.:1691249-45-2
Molecular Formula:C27H29N5O3
InChIKeys:InChIKey=RNOAOAWBMHREKO-QFIPXVFZSA-N
Molecular Weight:471.5
Exact Mass:471.55
UNII:AG9MHG098Z
NCI Thesaurus Code:C141428
ATC Code:L - Antineoplastic and immunomodulating agents
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Peptides,API,Intermediate
-
Location:
Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1
-
Payment Terms:
100% TT in advance
-
Average lead Time:
275
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product